Please use this identifier to cite or link to this item:
|Title:||WISDOM Will Australian women participate?|
|Citation:||Australian Family Physician, 2000; 29(8):797-801|
|Publisher:||Royal Australian College of General Practitioners|
|Abstract:||<h4>Aim</h4>This study investigated the likelihood of 50-69 year old women participating in the Women's International Study of long Duration Oestrogen after Menopause (WISDOM)--a 10 year randomised placebo controlled trial of hormone replacement therapy involving 10 years treatment plus a further 10 years follow up of major health outcomes.<h4>Methods</h4>The Health Monitor 2 (a representative population telephone survey) was used. Participants were 268 women aged 50-69 years from a total survey population of 2003 adults. Sociodemographic characteristics were collected.<h4>Results</h4>Of the women surveyed 20.9% indicated they were likely to participate and this was independent of sociodemographic characteristics and self reported health status. Women aged 50-54 were more likely to participate than older women.<h4>Discussion</h4>After allowing for exclusion criteria, it is estimated that approximately 10% of 50-69 year old women approached for recruitment in WISDOM may actually participate. There are likely to be sufficient altruistic women in this population to run WISDOM in Australia.|
|Keywords:||Humans; Placebos; Hormone Replacement Therapy; Data Collection; Demography; Menopause; Socioeconomic Factors; Aged; Middle Aged; Patient Participation; Australia; Female; Male; Randomized Controlled Trials as Topic|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.